Free Trial

ANI Pharmaceuticals (ANIP) SEC Filings & 10K Form

ANI Pharmaceuticals logo
$65.29 +0.07 (+0.11%)
As of 07/3/2025 01:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent ANI Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/16/2025
4:24 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:00 PM
ANI Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G
06/04/2025
6:10 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
5:15 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:16 PM
ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:17 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:18 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:19 PM
ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:21 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
7:05 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
7:10 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:21 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
7:50 AM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:14 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:15 AM
ANI Pharmaceuticals (Filer)
Form DEFA14A
04/14/2025
3:17 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:38 PM
ANI Pharmaceuticals (Filer)
Form DEF 14A
04/10/2025
3:40 PM
ANI Pharmaceuticals (Filer)
Form DEFA14A
04/10/2025
3:42 PM
ANI Pharmaceuticals (Filer)
Form ARS
03/31/2025
3:35 PM
ANI Pharmaceuticals (Filer)
Form PRE 14A
03/25/2025
3:44 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:47 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
4:17 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:19 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:20 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:22 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:28 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
7:50 PM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SCHEDULE 13D/A
03/11/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:28 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:06 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:07 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
6:05 AM
ANI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
3:33 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:11 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:12 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
02/18/2025
7:13 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:14 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:15 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:16 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:17 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:19 PM
ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:19 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:15 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:59 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:08 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:38 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:44 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:57 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:50 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:13 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:23 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:29 AM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:21 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:26 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:53 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:27 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:30 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:07 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:57 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANIP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners